SLYYYDEVentures
All Domains
06Neuro
Neuroscience
The brain remains the least-understood organ, but tools to read and write neural activity are advancing fast. Brain–machine interfaces promise to restore function and, eventually, augment it — raising profound product and ethical questions.
1,000selectrodes in next-gen brain interfaces
Neuro // visual intelligenceAdoption Readiness
Early40%
Frontier → Field-ready
Why Now
- Human brain–computer interface trials are underway
- AI is decoding neural signals with rising fidelity
- Neurotech venture funding is surging
Slyyyde Advisory
Neurotech venture strategy, BCI product ethics, evidence-based positioning.
On the Horizon
High-bandwidth brain–computer interfaces, closed-loop neurotherapeutics, and AI-decoded neural signals.
How we engage
- Neurotech venture and product strategy
- BCI ethics and safety frameworks
- Evidence-based clinical positioning
- Research partnership brokering
Application frontiers
Brain–computer interfacesNeurological therapeuticsCognitive healthAssistive technology
Converges with
Put Neuro to work
Book a briefing and our AI concierge will scope a neuro engagement tailored to your business before you ever meet a strategist.